Clinical Trial Update: Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease

View source ↗

Summary

The trial sponsored by Zagazig University evaluates Fetuin-A as a serum biomarker for diagnosing non-alcoholic fatty liver disease, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Zagazig University | Conditions: Non-Alcoholic Fatty Liver Disease | Status: COMPLETED